Gilead to end coronavirus drug trials, adding to access worry – researchers – The Star Online
- Gilead to end coronavirus drug trials, adding to access worry – researchers The Star Online
- Health groups ask India to rescind Gilead’s patents for Covid-19 drug remdesivir The Edge Markets MY
- Groups ask India to rescind Gilead’s COVID-19 drug patent Aljazeera.com
- Pakistan’s Ferozsons to Begin Producing COVID-19 Drug Remdesivir The New York Times
- Gilead may struggle to expand remdesivir’s market to moderately ill COVID-19 patients: analyst FiercePharma
- View Full coverage on Google News
Source: Business News Feed